Joanna Summers

NHS Blood and Transplant

Papers

2

Total Citations

249

H-Index

2

About

Joanna Summers is a leading researcher in prenatal diagnostics and fetal medicine, with a primary focus on noninvasive blood group typing to prevent hemolytic disease of the fetus and newborn. Her landmark 2008 prospective feasibility study, cited over 230 times, demonstrated the clinical utility of high-throughput automated robotic analysis of fetal DNA from maternal plasma to predict fetal RhD phenotype. This breakthrough enabled the targeted administration of anti-RhD immunoglobulin only to RhD-negative women carrying RhD-positive fetuses, dramatically reducing unnecessary treatment and conserving a limited blood product. Summers’ work has reshaped antenatal screening protocols, moving from universal prophylaxis to a precision medicine approach. Her research has been instrumental in advancing noninvasive prenatal testing (NIPT) technologies and has been widely adopted in clinical guidelines internationally. By integrating molecular genetics with obstetric care, Summers has significantly improved outcomes for RhD-negative pregnancies, preventing alloimmunization while optimizing healthcare resources. Her contributions continue to influence the evolution of fetal medicine and personalized prenatal care.

Research Focus

Key Achievements

2
H-Index
2
Papers
249
Total Citations
125
Avg Citations/Paper
🏆 Most Cited Paper
Effect of high throughput <i>RHD</i> typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study
231 citations · 2008
📈 Most Prolific Year: 2008 (2 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: NHS Blood and Transplant

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago